Tag: life sciences
-
Response by Patients Shown to Precision Lung Cancer Drug
Results of a clinical trial show a treatment targeting specific genetic aberrations produces a therapeutic response in most patients with lung cancer from that condition.
-
Sumitomo Dainippon, Biotechs in $3B Acquisition Deal
Japanese pharmaceutical company Sumitomo Dainippon agreed to acquire five biotechnology companies and gain an equity stake in the Roivant Sciences group.
-
Spin-Off Licensing Athletic Microbiome Technology
A company spun-off from biomedical engineering labs at Harvard University is acquiring research on microbial communities in elite athletes to create new probiotics.
-
Peanut Desensitizing Found Safe, Effective Long-Term
A clinical trial shows children with peanut allergies taking peanut protein under the tongue avoid allergic reactions from peanuts for up to five years.
-
Gates Investing in HIV, Tuberculosis Immunotherapies
The Bill and Melinda Gates Foundation is taking an equity stake in a biotechnology company developing immunotherapies from messenger RNA.
-
Urine Test Shows Promise for Cancer Screening
Biomedical engineers and materials scientists developed a simple urine test that in samples from lab mice show they can screen for colon cancer.
-
Deep Learning Techniques Speed Drug Discovery
Researchers developed and demonstrated techniques with deep learning to discover new small molecule drugs ready for validation and lab animal tests in 21 days.
-
Chip Device Simulates Islet Cell Functions
A new device testing the functions of insulin-producing islet cells in the pancreas is designed on a plastic chip made with common materials and manufacturing methods.
-
Robotic Device Navigates Brain Blood Vessels
Engineers and materials scientists designed a robotic device thin and flexible enough to thread through blood vessels in a model brain under remote control.
-
Companies Call for Genome Editing Regulations
A group of companies developing treatments for disease using genome editing are calling for regulations and standards to govern these technologies in regenerative medicine.